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Background: Formation of amyloid fibrils is accelerated by surfactants such as sodium dodecyl sulfate.
Results: Fibrillation of corneal dystrophy-associated peptides was accelerated by benzalkonium chloride, a cationic surfactant
widely used in eye drops.
Conclusion: The results suggest the potential risk that benzalkonium chloride in eye drops may accelerate amyloid fibrillation.
Significance: The results support the view of amylome that most proteins contain amyloidogenic sequences.
Corneal dystrophies are genetic disorders resulting in pro-
gressive corneal clouding due to the deposition of amyloid
fibrils derived from keratoepithelin, also called transforming
growth factor -induced protein (TGFBI). The formation of
amyloid fibrils is often accelerated by surfactants such as
sodiumdodecyl sulfate (SDS).Most eye drops contain benzalko-
nium chloride (BAC), a cationic surfactant, as a preservative
substance. In the present study, we aimed to reveal the role of
BAC in the amyloid fibrillation of keratoepithelin-derived pep-
tides in vitro. We used three types of 22-residue synthetic pep-
tides covering Leu110-Glu131 of the keratoepithelin sequence:
an R-type peptide with wild-type R124, a C-type peptide with
C124 associated with lattice corneal dystrophy type I, and a
H-type peptide withH124 associated with granular corneal dys-
trophy type II. The time courses of spontaneous amyloid fibril-
lation and seed-dependent fibril elongation were monitored in
the presence of various concentrations of BAC or SDS using
thioflavin T fluorescence. BAC and SDS accelerated the fibrilla-
tion of all synthetic peptides in the absence and presence of
seeds. Optimal acceleration occurred near the CMC, which sug-
gests that the unstable and dynamic interactions of keratoepi-
thelin peptides with amphipathic surfactants led to the forma-
tion of fibrils. These results suggest that eye drops containing
BAC may deteriorate corneal dystrophies and that those with-
out BAC are preferred especially for patients with corneal
dystrophies.
The deposition of amyloid fibrils is associated with amyloid-
oses, including Alzheimer disease, dialysis-related amyloidosis,
and corneal dystrophy (1–5). Although an increasing amount of
information on amyloid proteins and their precursors has accu-
mulated with the advent of analytical methods, the molecular
mechanisms underlying the formation of amyloid fibrils (i.e.
amyloid fibrillation) and developing amyloidoses are still
unclear. Corneal dystrophy, one formof amyloidoses, is a group
of disorders characterized by the primary, inherited, and pro-
gressive opacity of both corneas (1, 4). In advanced cases,
patients becomeblind. Although the several treatments for cor-
neal dystrophy including corneal transplantation are known,
recurrence of the disease is inevitable. Genetic analysis has
revealed that mutations in keratoepithelin, an extracellular
matrix protein that is composed of 683 amino acids and is
folded into four constitutive domains, are responsible for sev-
eral corneal dystrophies (Fig. 1) (1, 4). Keratoepithelin is also
known as the transforming growth factor -induced protein
(TGFBI).3 The three-dimensional structure of keratoepithelin,
except for one domain, has not yet been identified (Fig. 1). On
the other hand, it is likely that, instead of the whole protein
molecule, the fragments of keratoepithelin produced after par-
tial proteolysis may be responsible for amyloid fibrillation,
although the details are unclear.
Hereditary corneal dystrophies are characterized by the
abnormal deposition of amyloid fibrils and/or granular aggre-
gation in the cornea (6–9). Population analyses have revealed
two hot spots of mutation at R124 and R555 (7, 10). The posi-
tion of R124 in particular has four different mutations that lead
to distinct phenotypes: R124C (lattice corneal dystrophy type
I), R124H (granular corneal dystrophy type II, also called Avel-
lino type), R124L (granular corneal dystrophy type III), and
R124S (granular corneal dystrophy type I). Although keratoepi-
thelin is expressed throughout the body, including the skin,
conjunctiva, and kidneys, the deposition of amyloid fibrils has
been observed in the cornea only (11). Furthermore, the intrin-
sic and extrinsic risk factors that accelerate corneal dystrophies
are unknown.
Previously, Schmitt-Bernard et al. (8) studied the amyloido-
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Glu-131 of the keratoepithelin sequence and its mutants:
R124C (C-type) and R124H (H-type) peptides. The results indi-
cated that these mutations enhanced the amyloidogenicity of
the wild-type peptide (R-type), which implied an underlying
mechanism of R124 mutation-linked corneal dystrophies.
In addition to the intrinsic amyloidogenicity determined by
the amino acid sequence, various extrinsic factors such as pH,
solvents, metal ions, membranes, and surfactants affect amy-
loidogenicity (12, 13). Moreover, the exposure of amyloido-
genic regions by denaturation is essential to induce their fibril-
lation (14–17). Among various surfactants, sodium dodecyl
sulfate (SDS), an anionic surfactant, is most widely used as an
inducer of amyloid fibrils in vitro (18–22). SDS above the crit-
ical micelle concentration (CMC) was shown to denature pro-
teins, where SDS micelles accommodated denatured proteins
so as to increase their solubility (23). Such high concentrations
of SDS were also shown to depolymerize preformed amyloid
fibrils. Upon denaturation or depolymerization by SDS above
CMC, denatured proteins assumed an open -helical confor-
mation, in which interactions between -helices were weak
(23, 24).
Recently, the effects of SDS mimicking some characteristics
of lipids constituting biological membranes (22, 23) on acceler-
ating the amyloid fibrillation at around or slightly below CMC
have been reported (18–22). In our previous study, we showed
that the amyloid fibrillations of the C-type andH-type peptides
were accelerated by low concentrations of SDS slightly below
CMC (25). However, the pathological significance of SDS in
amyloidoses is unclear because SDSdoes not exist in the human
body.
Here, benzalkonium chloride (BAC), a cationic surfactant,
may be clinically important in the pathogenesis of corneal dys-
trophies. In most commercially available eye drops, various
antiseptic reagents, includingmethyl 4-hydroxybenzoate, ethyl
4-hydroxybenzoate, and BAC, are added, among which BAC is
the most widely used (26). Patients with corneal dystrophies
frequently use eye drops because of corneal irritation and
inflammation, which exposes their corneas to BAC more than
others. Considering the marked effects of SDS on the fibrilla-
tion of keratoepithelin-derived peptides (25), we anticipated
similar effects from BAC.
In the present study, ultrasonic treatment, one of the most
powerful methods for accelerating spontaneous fibrillation in
vitro, was used to efficiently investigate the amyloid fibrillation
of keratoepithelin-derived peptides (27–30).We used the wild-
type R-peptide and disease-associated C-type and H-type pep-
tides.We demonstrated that the fibrillations of these 3 peptides
were accelerated in the presence of BAC, as was the case with
SDS, where the most effective concentrations were around
CMC. These results indicate that the accelerating effects on
fibrillation at around CMC are common to various detergents,
and also suggest a possible relationship between the preserva-
tives in eye drops and the development of corneal dystrophies.
EXPERIMENTAL PROCEDURES
BAC and SDS—BAC also known as alkyldimethylbenzylam-
monium chloride is a cationic surfactant with a quaternary
ammonium group and an alkyl group of various chain length
(Fig. 2A, r -C8H17 . . . -C18H37). In this study, wemainly used
a sample with 98%-C14H29 BAC (BAC(C14)) (Nacalai Tesque
Inc, Kyoto, Japan) because it ismostwidely used as an antiseptic
reagent. We also used analogues of BAC with C12H25
(BAC(C12)) and C16H33 (BAC(C16)) alkyl groups, which were
purchased from Sigma-Aldrich . SDS, an anionic surfactant
(Fig. 2B), was purchased from Nacalai Tesque Inc. (Kyoto,
Japan).
CMC—The CMC values of BAC and SDS were determined
using 8-anilino-1-naphthalenesulfonic acid (ANS), a fluores-
cence probe to detect water-accessible hydrophobic regions.
The micelle-dependent increase in ANS fluorescence was
measured with excitation and emission wavelengths of 385 nm
and 475 nm, respectively, using a Hitachi spectrophotometer
Model F-7000 (Hitachi, Ibaraki, Japan) (19). The reaction mix-
tures in 50 mM sodium phosphate buffer (pH 7.9), 100 mM
NaCl, 10 M ANS, and various concentrations of BAC or SDS
were analyzed at 37 °C after incubation for 30 min at the same
temperature. The CMC values were determined from the
dependence of ANS fluorescence on its concentration, where
the crossing point of two linear lines represents the CMC.
Formation of Amyloid Fibrils—Chemically synthesized R-,
H-, and C-type peptides (Fig. 1) were purchased from the Pep-
tide Institute, Inc. (Osaka, Japan). These peptides were dis-
solved in a small volume of 100% dimethyl sulfoxide and left for
30 min to dissolve completely. The peptide solutions (400 M)
were then prepared using 50 mM sodium phosphate buffer (pH
7.0) with 100 mM NaCl, 5 M ThT, and various concentrations
(0 to 1.5 mM) of the surfactants (BAC or SDS). To accelerate
fibrillation, ultrasonic pulses were applied to the peptide solu-
tions by a water-bath-type ultrasonicator, ELESTEIN (Elekon
ScienceCo., Ltd., Chiba, Japan) at 37 °C. The frequency of ultra-
sonication was near 19 kHz, and cycles of 1min ultrasonication
and 9min quiescencewere repeated (28).We also examined the
effects on fibrillation of stirring the solutions with a magnetic
bar at 37 °C.
FIGURE 1. Structural model of keratoepithelin. The image shows a simpli-
fied diagram of keratoepithelin, which comprises cysteine-rich domain (EMI),
four fasciclin 1 domains (FAS1), and an Arg-Gly-Asp (RGD) motif. Arg-124 and
Arg-555 residues are hot mutations related to some corneal dystrophies. The
crystal structure shows a FAS1– 4 domain from human keratoepithelin (PDB
ID: 2vxp). The synthesized peptides derived from the 110 –131 residues of the
FAS1–1 domain contain the Arg-124 residue. R124H (H-type) and R124C
(C-type) mutations cause Avellino and classic lattice corneal dystrophy,
respectively. R-type represents the wild-type.
BAC Induced Keratoepithelin Fibrillation





















In the seeding experiments, seeds were prepared by the frag-
mentation of preformed fibrils with a Microson XL (Misonix,
Inc., Farmingdale, NY). The seeds were added at a final concen-
tration of 20 g/ml to 400 M peptides in 50 mM sodium phos-
phate (pH 7.0) containing 100 mM NaCl at 37 °C.
ThT Fluorescence Assay—ThT specifically binds to amyloid
fibrils and consequently produce enhanced light emission (18,
31, 32). The formation of amyloid fibrils was monitored with
theThT fluorescence assay using amicroplate (Greiner bio-one
96-well microplate 675–074, made of polystyrene) and a
microplate reader (MTP-810, Corona Electric Co., Ibaraki,
Japan). Fluorescence was measured with excitation and emis-
sion wavelengths of 450 nm and 490 nm, respectively (31, 32).
The lag time was defined by the time to achieve a half-maxi-
mum ThT intensity.
Transmission Electron Microscopy—Samples containing
amyloid fibrils were diluted 10-foldwithwater and immediately
placed on carbon-coated copper grids (400 mesh). Excess solu-
tion was removed with filter paper after the sample had stood
for 1 min. The fibrils adsorbed on the grid were negatively
stainedwith a 2% (w/v) uranyl acetate solution. Electronmicro-
graphswere acquired using a transmission electronmicroscope
(TEM) (Hitachi, H-7650) with an acceleration voltage of 80 kV.
Reverse-phased High Performance Liquid Chromatography
(RP-HPLC) Experiments—The C-type peptide was dissolved in
a small volume of 100% dimethyl sulfoxide (DMSO) and left for
30min to dissolve completely. 50 mM sodium phosphate buffer
(pH 7.0) was then added. 20mM dithiothreitol (DTT) was addi-
tionally added to the reduction sample to reduce disulfide bond.
Amyloid fibrils were prepared with seed-dependent fibrilla-
tion in the presence of 0.03 mM BAC or 0.7 mM SDS. The sam-
ples were centrifuged at 4 °C for 30 min (15,000 rpm) and the
precipitated fibrils were recovered. 1,1,1,3,3,3-hexafluoroiso-
propanol (HFIP)was then added to depolymerize the fibrils and
the reaction mixture was incubated at room temperature for
6 h. The depolymerized samples were analyzed by RP-HPLC
with a GILSON liquid chromatogram equipped with a C4-AR-
300 column (4.6 150 nm) (Nacalai Tesque, Inc., Kyoto, Japan)
at a flow rate 0.5 ml/min.
RESULTS
Measurement of CMCs—SDS is a surfactant and its effects on
amyloid fibrillation have been studied extensively (18–22). The
effects of SDS differ significantly depending on its concentra-
tion, and concentrations of SDS around or slightly lower than
CMC have been shown to generally accelerate amyloid fibrilla-
tion. In contrast, SDS higher than CMC inhibited fibrillation
because of the detergent effects arising from SDS micelles (22,
23). Thus, determining the CMC value is important in evaluat-
ing the effects of a surfactant on amyloid fibrillation. The
dependence of ANS fluorescence on the concentration of BAC
or SDS showed a clear change in the slope, where a crossing
point of the two lines represents the CMC (Fig. 2, C–F). From
these plots, the CMC values for BAC(C12), BAC(C14), and
BAC(C16) were determined to be 0.15, 0.02, and 0.0025 mM,
respectively, in 50 mM sodium phosphate buffer (pH 7.0) con-
taining 100 mM NaCl at 37 °C. The CMC value of SDS was also
determined to be 1.0 mM under the same conditions.
Effects of BAC on Spontaneous Fibrillation—We first exam-
ined the spontaneous fibrillation of keratoepithelin-derived
peptides in the presence of various concentrations BAC(C14),
the most abundant BAC in eye drops. Under quiescent condi-
tions, the fluorescence of ThT did not significantly increase
over periods of 2 weeks. Therefore, we applied ultrasonic agi-
tations to accelerate fibrillation (28). Fig. 3,A–C show the kinet-
ics of fibrillation of the R-, C-, and H-type peptides, respec-
tively, in the presence of BAC(C14) at 0–1.5 mM. BAC(C14) at
0.01, 0.03, and 0.05 mM accelerated the amyloid fibrillation for
all the peptides. The dependence of the final ThT fluorescence
against the BAC(C14) concentration for R- andH-type peptides
showed a bell-shape profile with an optimum at around CMC
(0.02 mM) (Fig. 3D). In the case of the C-type peptide, the max-
imum ThT intensity shifted to a higher concentration of
BAC(C14), suggesting that the C-type peptide was distinct from
the other two peptides. We found that the fibrils of the C-type
peptide were dominantly formed by dimers linked by an inter-
molecular disulfide bond (see below).
Interestingly, the R-type peptide formed fibrils under ultra-
sonic conditions, which indicates that this region of wild-type
keratoepithelin exhibits amyloidogenicity regardless of the
mutation. Prediction analyses suggested that aggregation pro-
pensities near the mutation site R124 were not very high and,
moreover, mutations did not increase the propensity signifi-
cantly (see “Discussion”). We then calculated the lag time,
which represented the time required to form an amyloid
nucleus, in the presence of 0–0.5 mM BAC(C14) (Fig. 3E). The
lag time of all the synthetic peptides became shorter with
FIGURE 2. Molecular structures and CMCs of BAC and SDS. A and B, chem-
ical structures of BAC (A) and SDS (B). C–F, determination of CMCs for BAC(C12
(C), C14 (D), and C16 (E)) and SDS (F) using ANS fluorescence. The CMC values of
BAC and SDS were determined to be 0.15 mM (BAC(C12) (C)), 0.02 mM
(BAC(C14) (D)), 0.0025 mM (BAC(C16) (E)), and 1 mM (SDS (F)), respectively.
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increasing concentrations of BAC(C14). These results indicate
that BAC(C14) accelerates the formation of amyloid nuclei in
proportion to its concentration. On the other hand, high con-
centrations of BAC(C14), especially those higher than 0.5 mM,
inhibited fibrillation when monitored by ThT fluorescence.
Interestingly, although the ThT fluorescence decreased, the lag
time remained shorter, suggesting that the inhibition of fibril-
lation occurred because of the accelerated formation of amor-
phous aggregates at high concentrations of BAC(C14). Such a
competitive mechanism of amyloid fibrillation and amorphous
aggregation has been proposed for the alcohol or SDS-induced
amyloid fibrillation (19).
Effects of SDS on Spontaneous Fibrillation—We also exam-
ined the effects of SDS. A reaction mixture containing a low
concentration of SDS formed amyloid fibrils within several
days, even without sonication (25). With ultrasonication, amy-
loid fibrillation reached a plateau within several hours (data not
shown). The maximum fluorescence intensity was obtained at
aroundCMC (1.0mM) for all types of peptides (Fig. 3F), and the
lag time became shorter with increasing concentrations of SDS
(Fig. 3G). Interestingly, although both cationic BAC and ani-
onic SDS accelerated fibrillation at around their CMC, the
effects of BAC(C14) on the lag time were about 10-fold higher
than those of SDS: The maximal concentrations of BAC(C14)
and SDS were 0.01 mM and 0.7 mM, respectively.
Morphology of Spontaneously Formed Fibrils—Fibrils ob-
served by TEM (Fig. 4 and Fig. 5) showed that, in the absence of
BAC and SDS, the morphologies of these fibrils were distinct
among the 3 peptides. The protofibrils of the R- and H-type
fibrils interacted with each other to form a sheet-like morphol-
ogy (Figs. 4,A, I, and 5,A, I). In the case of theC-type fibrils, thin
and long rigid fibrils formed under ultrasonic conditions (Figs.
FIGURE 3. Fibril formations of the synthetic R-, C-, and H-type peptides at various concentrations of BAC and SDS. A–C, time courses of fibrillation at
various concentrations of BAC. D and E, dependence of the amount of fibrils (D) and the lag time (E) on the BAC concentrations. F and G, dependence of the
amount of fibrils (F) and the lag time (G) on the SDS concentrations.
FIGURE 4. High-magnification TEM images of the amyloid fibrils of the R-
(A–D), C- (E–H), and H-type (I–L) peptides in the absence and presence of
BAC. The BAC concentrations were 0 (A, E, and I), 0.01 (B, F, and J), 0.3 (C, G, and
K), and 1.5 mM (D, H, and L). When the concentration of BAC was increased, the
bundles of amyloid fibrils became thicker in the R- and H-type peptides. The
scale bars represent 200 nm.
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4E and 5E). In the presence of BAC(C14) at around CMC, the
morphologies of the 3 types of fibrils were similar to those
formed in the absence of surfactants (Fig. 4, B, F, and J). At high
concentrations of BAC, the R- and H-type peptides formed
sheet-like fibrils (Fig. 4,C-D andK-L). Themorphologies of the
fibrils made from the R- and H-type peptides were similar,
independent of BAC(C14) concentrations. In contrast, the
C-type fibrils exhibited distinct morphologies at around and
above CMC. At high concentrations of BAC(C14), the C-type
fibrils exhibited short and sheet-likemorphologies, which were
similar to those of the R- and H-type fibrils (Fig. 4,G andH). In
general, fragmented fibrils were observed under ultrasonic con-
ditions. The C-type fibrils formed at around CMC were rela-
tively long. These images suggested that C-type fibrils have
tight intermolecular interactions than those of R- and H-type
fibrils.
We also performed TEMmeasurements of the fibrils formed
in the presence of SDS (Fig. 5). In the case of R- and H-type
fibrils, we obtained similar fibril images to those in the presence
of BAC, which suggests that the fibrils of these peptides do not
depend on the type of surfactant present (Fig. 5,B-D and J-L). In
contrast, with increasing concentrations of SDS, fine fibrillar
structures were seen for the C-type fibrils (Fig. 5, F–H). How-
ever, we often observed more fragmented fibrils in the TEM
images obtained at high SDS concentrations than in those near
CMC, which indicates that the stability of fibrils decreased at
high concentrations of SDS.
Effects of BAC Analogues with Different Alkyl Groups on
Fibrillation—Although BAC(C14) is widely used as an antisep-
tic reagent, there are analogues of BAC with different alkyl
chain length. Here, we compared the effects of 3 types of BAC
analogues with C12, C14, and C16 alkyl groups. It is noted that
the effects of these BACanalogues on the cell toxicity have been
examined (33). The effects of these analogues on fibrillation
were examined withH-type peptide under ultrasonication (Fig.
6). For all the three types of BAC analogues, fibrillation was
accelerated at aroundCMC: 0.12mM for BAC(C12), 0.01mM for
BAC(C14), and 0.002 mM for BAC(C16) (Fig. 6A). As described
before, the CMC values for BAC(C12), BAC(C14), and
BAC(C16) were 0.15, 0.02, and 0.0025 mM, respectively. These
results indicate that the optimal amyloid fibrillation around the
CMC value of BAC is common to various BAC analogues with
different alkyl chain length (Fig. 6, B and C).
Seed-dependent Growth of Fibrils—Amyloid fibrils grow
without a lag phase upon the addition of fibril templates, which
is called a seeding reaction. Patients with corneal dystrophies
already have potential amyloid seeds due to abundant kera-
FIGURE 5. High-magnification TEM images of amyloid fibrils of the R-
(A–D), C- (E–H), and H-type (I–L) peptides in the absence and presence of
SDS. The SDS concentrations were 0 (A, E, and I), 0.01 (B, F, and J), 0.3 (C, G, and
K), and 1.5 mM (D, H, and L). The addition of SDS did not have any significant
effects on the morphology of the amyloid fibrils. The scale bars represent
200 nm.
FIGURE 6. Fibril formation of the synthetic H-type peptide using BAC ana-
logues. A, time courses of fibrillation at various concentrations of BAC(C12),
BAC(C14), and BAC(C16). B, dependence of the amount of fibrils on the con-
centrations of BAC(C12), BAC(C14), and BAC(C16). C, dependence of the lag
time on the concentrations of BAC(C12), BAC(C14), and BAC(C16).
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toepithelin and its proteolytic products in the corneal stroma.
To address the effects of BAC-containing eye drops on corneal
dystrophies, we investigated in vitro seeding reactions. Fig. 7
shows the effects of BAC(C14) on the seed-dependent fibrilla-
tion of the R-, C-, and H-type peptides. Depending on its con-
centration, BAC(C14) accelerated the seeding reaction of the R-
and H-type peptides. Concerning the R-type peptide, 0.01–0.1
mM BAC(C14) accelerated the seeding reaction. At high con-
centrations of BAC(C14) (0.5mMBAC(C14)), the accelerating
effect was not evident (Fig. 7, A and D). The results of the
H-type peptide were similar to those of the R-type peptide,
which exhibited marked effects for 0.01–0.05 mM BAC(C14)
and minimal effects at higher concentrations (Fig. 7, C and D).
In contrast, the seeding reactions of the C-type peptide were
distinct from the others (Fig. 7, B and D). The seeding effects
were observed at all BAC(C14) concentrations, except for 1.0
mMBAC(C14). Additionally, the ThT intensities of several sam-
ples at time 0 were markedly high, indicating that the seeding
ability of the C-type peptide was larger than that of the other
peptides. This marked amyloidogenicity of the C-type peptide
may have been caused by dimer formation linked by a disulfide
bond (see below).
We also examined the effects of SDS on seeding reactions
using the R-, C-, and H-type peptides (Fig. 7E). As was the case
with BAC(C14), the presence of SDS accelerated the seeding
reaction, the maximum of which was observed at around CMC
(1 mM).
TEMwas used to observe the morphologies of fibrils formed
seed-dependently in the presence of BAC (Fig. 8) or SDS (Fig.
9). All the amyloid fibrils obtained exhibited well-ordered and
straight morphologies. Because the seeding reactions were per-
formed under quiescent conditions, we did not observe the
fragmented fibrils detected with the ultrasonic treatment. It
appears that the addition of surfactants did not have significant
effects on the structure of amyloid fibrils. On the other hand,
these surfactants accelerated the fibrillation kinetics at around
CMC and also increased the amount of fibrils for all 3 types of
peptides.
Our results indicate that low concentrations of BAC(C14)
equivalent to those present in eye drops can promote the fibril-
lation of both the C- and H-type peptides, associated with cor-
neal dystrophies, as well as the wild-type R-type peptide for
both spontaneous and seed-dependent fibrillations.
Comparison of Ultrasonication and Stirring—Although
ultrasonication effectively induced the amyloid fibrillation in
the presence of BAC, the effects might be specific to ultrasoni-
cation. To address the generality of the BAC effects, we exam-
ined the effects of stirring, a widely used agitation, on the fibril-
FIGURE 7. Seeding reactions of the R-, C-, and H-type peptides in the presence of various concentrations of BAC and SDS. A–C, time courses of fibrillation
at various concentrations of BAC. D and E, dependence of the maximum ThT fluorescence on the BAC (D) and SDS (E) concentrations. The seeds were added at
5% (v/v) to the monomers.
FIGURE 8. High-magnification TEM images of seed-dependent amyloid
fibrils with the various concentrations of BAC. R- (A–D), C- (E–H), and
H-type (I–L) peptides. BAC was added at 0 (A, E, and I), 0.01 (B, F, and J), 0.1 (C,
G, and K), and 1.0 mM (D, H, and L). The scale bars represent 200 nm.
BAC Induced Keratoepithelin Fibrillation





















lation of H-type peptide in the presence of BAC(C14).
Fibrillation of H-type peptide occurred by stirring in the pres-
ence of 0.01 mM BAC(C14) (data not shown), although the
effects were less than those of ultrasonication in terms of the
ThT intensity. The results indicate that the BAC-dependent
fibrillation is general independent of a type of agitation.
DISCUSSION
Effects of Surfactants on Amyloid Fibrillation—Surfactants,
in particular SDS, are known to accelerate or inhibit amyloid
fibrillation depending on their concentration (18–22). The
purpose of the present study was to investigate the role of BAC,
the most widely used cationic surfactant, in the amyloid fibril-
lation of keratoepithelin-derived synthetic peptides, with a
focus on the mutations found in corneal dystrophies. We
observed that BAC(C14), especially at a concentration around
CMC (0.02 mM), accelerated both the nucleation and elonga-
tion of amyloid fibrillation for all 3 peptides (R-, C-, andH-type
peptides) (Fig. 3). The acceleration of the H-type fibrillation
also occurred for BAC(C12) and BAC(C16) indicating the gen-
erality of the BAC effects (Fig. 6).
The acceleration of amyloid fibrillation may have occurred
through the direct interaction between the surfactant and pep-
tide molecules. The binding of surfactants to the peptides
occurs by the combined effects of electrostatic and hydropho-
bic interactions. All 3 peptides contain the same acidic amino
acids (Asp andGlu) at the same position. In contrast, the R- and
H-type peptides contain 3 (Arg, Lys, and His) and the C-type
peptide contains 2 (Lys and Arg) basic amino acids in their
sequences. The isoelectric points of the 3 peptides were 6.18
(R-), 4.68 (C-), and 5.45 (H-type) on the basis of the pKa values
of charged groups (34, 35), which indicates that, at physiologi-
cal pH, the binding affinity of SDS to theC-type peptide is lower
than that of the R- and H-type peptides.
BothBAC(C14) and SDS accelerated the nucleation and elon-
gation process of amyloid fibrillation (Fig. 3). However, the
acceleration by BAC(C14) occurred at concentrations much
lower than those by SDS. In the presence of BAC(C14), themax-
imumamount of amyloid fibrils was detected at 0.01mM for the
H- and R-type peptides and at 0.1mM for the C-type peptide. In
contrast, the maximum amount of fibrils was detected at 0.7
mM SDS for the R- and H-type peptides and at 0.5 mM SDS for
the C-type peptide. This difference in the optimal concentra-
tion is consistent with the difference in the CMC values of
BAC(C14) (0.02 mM) and SDS (1 mM), which confirm the
importance of CMC in the mechanism of fibrillation. The opti-
mal concentrations of BAC(C12) and BAC(C16) for acceleration
of the H-type fibrillation were 0.12 and 0.02 mM, respectively.
These values are close to their CMC values of 0.15 and 0.0025
mM, respectively, further confirming the importance of CMC
(Fig. 6).
As discussed previously, when detergents exist at slightly
below CMC, they start to interact with each other via hydro-
phobic interactions; however, the concentration is not enough
to stabilizemicelles. The presence of hydrophobic peptides per-
turbs the equilibrium by interacting with detergents, promot-
ing the association of detergents. However, the conformational
flexibility of peptides prevents the formation of ordered
micelle-like structures; instead, they induce the non-organized
association of a mixture of detergents and peptides, leading to
amorphous aggregates and phase separation as amorphous pre-
cipitates (19, 23). However, as for some proteins and peptides,
amyloid fibrils are more stable than amorphous aggregates,
eventually leading to the formation of fibrils (19, 22, 23).
Effects of Agitation onAmyloid Fibrillation—In this study, we
used ultrasonication to accelerate the amyloid fibrillation.
Ultrasonic treatment is one of the most powerful methods for
accelerating spontaneous fibrillation in vitro (30). Irradiation of
an aqueous solution with ultrasonic pulses produces cavitation
microbubbles that repeatedly grow and collapse in synchrony
with the driving ultrasonic amplitude. The hydrophobic surface
of cavitation microbubbles absorbs protein molecules, trigger-
ing the amyloid nucleation. The cavitation-induced solvent
flow producing shearing force is effective to break down the
preformed fibrils and thus to activate secondary nucleation.
On the other hand, more conventional method to accelerate
the fibrillation is stirring the solution by a magnetic bar. The
fibrillation ofH-type peptidewas indeed accelerated by stirring,
although the effects were less than those of ultrasonicationwith
respect to theThT fluorescence intensity (data not shown). The
results indicate that the BAC-dependent fibrillation is general
independent of a type of agitation and might be possible to
occur under physiological conditions, where unknown factors
might trigger nucleation.
Difference among the R-, C-, and H-type Peptides—The reac-
tions of the R- and H-type peptides with BAC(C14) were differ-
ent from those of theC-type peptide. For example, although the
dependence of the lag time on the concentration of BAC(C14)
was similar among the 3 peptides, the lag time of the C-type
peptide was about 2-fold longer than that of the R- and H-type
peptides. Moreover, the maximal ThT fluorescence of the
C-type peptide was observed at 0 and 0.1 mM for spontaneous
and seed-dependent fibrillations, respectively, indicating the
absence of a clear relationship between the maximumThT flu-
FIGURE 9. High-magnification TEM images of seed-dependent amyloid
fibrils with the various concentrations of SDS. R- (A–D), C- (E–H), and
H-type (I–L) peptides. SDS was added at 0 (A, E, and I), 0.01 (B, F, and J), 0.1 (C,
G, and K), and 1.0 mM (D, H, and L). The addition of SDS did not have any
significant effects on the morphology of the amyloid fibrils. The scale bars
represent 200 nm.
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orescence intensity and CMC value. The addition of BAC(C14)
may have hidden the apparent effects of seeding by accelerating
the overall reactions.
The high amyloidogenicity of the C-type peptide may be
attributed to the formation of disulfide bonds between them.
Previously, using this C-type peptide of 22-residues and a dial-
ysis-based approach, Schmitt-Bernard et al. (8) reported that
blocking free thiol groups to prevent the formation of disulfide
bond resulted in a decrease in amyloid fibrillation. To confirm
the role of disulfide linkage, we depolymerized C-type fibrils
using HFIP and analyzed the oligomeric states by reverse-
phased high performance liquid chromatography (data not
shown). The results showed that almost all depolymerized
C-type peptides assumed dimers, which indicates that the
disulfide bond promotes fibrillation.
Several examples have shown that the formation of dimers
and higher oligomers by disulfide linkages increased the amy-
loidogenicity of peptides (36, 37). Thus, the increased amy-
loidogenicity of disulfide linked peptides and proteins are likely
to be a common property, although the biological significance
in corneal dystrophies is unknown.
In addition, the net charge of the peptides is an important
factor in determining the reactions between peptides and BAC,
and, thus, their amyloidogenicity. His and Arg residues have a
positive charge, while the Cys residue is neutral under physio-
logical pH conditions. The more positively charged H- and
R-type peptidesmay interactwith negatively charged SDSmore
than the C-type peptide. On the other hand, they interact with
positively charged BAC less tightly than that of the C-type pep-
tide. These attractive interactions may decrease the concentra-
tion of monomeric detergents so as to increase the apparent
CMC values.
Comparison of in Vitro and in Vivo Models—We anticipated
that the wild-type R-type peptide would have the lowest amy-
loidogenicity. Interestingly, amyloid fibrillations were seen for
all R-, C-, and H-type peptides. This result indicates that, in
addition to the mutation, additional factors are involved in the
pathogenesis of corneal dystrophies in vivo. Although kera-
toepithelin is expressed in various organs, including the skin
and kidneys, amyloid fibrils were seen in the cornea only (11),
which emphasizes the importance of tissue-specific additional
factors.
One of these additional factors may be the post-translational
processing of keratoepithelin (7, 38). Abnormal post-transla-
tional glycation, D--Asp racemization, and proteolysis have
been shown to be involved in amyloid fibrillation in corneal
dystrophies (38, 39). In addition, because many amyloidogenic
sequences are buried or have a non-amyloidogenic conforma-
tion, denaturation has been suggested to make these proteins
amyloidogenic. Several methods have been proposed to predict
the amyloidogenic or aggregative propensities of proteins and
peptides, such as TANGO (40), Zyggregator (41), AGGRESCAN
(42), PASTA (43), and 3D profiling (44). A recent approach to
predicting the amyloidogenicity of proteins with 3D profiling
has coined the term “amylome”, and proposes that practically
all human proteins contain an amyloidogenic sequence (16).
We performed prediction analyses by Zyggregater (41) and
AGGRESCAN (42) to compare the aggregation propensities of
the R-, C-, and H-type peptides (Fig. 10). The aggregation pro-
pensity near mutation site R124 was not very high. Although
the aggregation propensity increased slightly upon the R to C
mutation, there was no clear difference among the 3 peptides.
We still do not know the critical length of the keratoepithelin
peptides in the amyloid deposits of patients as well as the entire
three-dimensional structure of the intact keratoepithelin mol-
ecule (Fig. 1). It is probable that the amyloidogenicity of kera-
toepithelin is revealed upon the denaturation and consequent
exposure of the amyloidogenic regions, and that disease-asso-
ciated mutations decrease the stability of the native conforma-
tion. It is also possible that mutations affect other post-transla-
tional processes, leading to the accelerated exposure of the
amyloidogenic sequence and, thus, to the development of cor-
neal dystrophies (7, 8).
Risk of BAC on Cornea Dystrophies—Various antiseptic
reagents, including BAC, ethyl parahydroxybenzoate, and
methyl parahydroxybenzoate, are added to most commercially
available eye drops. BAC(C14) is the most widely used among
them because it has a broad spectrum of activity on most path-
ogenic microorganisms and relatively low toxic effects on the
cornea (26). The concentration of BAC(C14) in eye drops is
0.001–0.02% (0.03–0.6 mM), which indicates that the maxi-
mum concentration of BAC in the cornea after instillation
would be more than its CMC (0.02 mM). This finding suggests
the potential risk that BAC(C14) in eye drops may accelerate
amyloid fibrillation in patients with corneal dystrophies as well
as in thosewith the potential of developing corneal dystrophies.
There has been no etiological data identifying the use of
BAC(C14)-containing eye drops as a deteriorating factor of cor-
neal dystrophies. However, it would be reasonable to prescribe
FIGURE 10. Aggregation propensities of Fas1–1 domain of keratoepithe-
lin. A–D, predicted aggregation propensities by Zyggregator (41) (A and B),
and AGGRESCAN (42) (C and D). The regions of synthesized peptides are
expanded in B and D. The mutation site R124 is indicated by arrows.
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BAC(C14)-free eye drops to patients, especially those with cor-
neal dystrophies.
Conclusion—We investigated the in vitro effects of BAC(C14),
an antiseptic reagent widely used in most commercially
available eye drops, on amyloid fibrillation using 22-residue
synthetic peptides corresponding to those found in corneal dys-
trophies. Using our in vitro system with ultrasonication for
accelerated fibrillation, we identified the fibrillation of disease-
associated H- and C-peptides as well as the wild-type R-pep-
tide. These results support the views of amylome that most
proteins contain amyloidogenic sequences and that additional
factors disclosing the hidden amyloidogenicity may be
more important than the intrinsic amyloidogenicity of the
amino acid sequence for clarifying the biological impact of
amyloidogenicity.
Using the current system with ultrasonication for acceler-
ated fibrillation, we can evaluate the effects of various reagents
on amyloid fibrillation within a week. In addition to BAC(C14),
each component of various eye drops should be evaluated to
clarify its potential risk of amyloid fibrillation. The information
obtained will be useful in selecting safer medications for
patients with corneal dystrophies as well as for normal people.
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